H B Carter

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer
    H B Carter
    Department of Urology, Johns Hopkins Hospital, Baltimore, MD 21287 2101, USA
    JAMA 277:1456-60. 1997
  2. ncbi Prostate-specific antigen testing of older men
    H B Carter
    Department of Urology, The Johns Hopkins University School of Medicine, The James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, MD 21287 2101, USA
    J Natl Cancer Inst 91:1733-7. 1999
  3. ncbi Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer
    S M Harman
    The Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA
    J Clin Endocrinol Metab 85:4258-65. 2000
  4. ncbi Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of Aging
    J Fang
    National Institute on Aging, Gerontology Research Center, Baltimore, Maryland, USA
    Urology 58:411-6. 2001
  5. ncbi Prediction of significant cancer in men with stage T1c adenocarcinoma of the prostate
    H B Carter
    Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    World J Urol 15:359-63. 1997
  6. ncbi Dedifferentiation of prostate cancer grade with time in men followed expectantly for stage T1c disease
    J I Epstein
    Department of Urology, The Johns Hopkins University School of Medicine, The James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, Maryland 21231, USA
    J Urol 166:1688-91. 2001
  7. ncbi Plasma selenium level before diagnosis and the risk of prostate cancer development
    J D Brooks
    Department of Urology, Stanford University Medical Center, Stanford, California, USA
    J Urol 166:2034-8. 2001
  8. ncbi Importance of posterolateral needle biopsies in the detection of prostate cancer
    J I Epstein
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Urology 57:1112-6. 2001
  9. ncbi Effect of local anesthetics on patient recovery after transrectal biopsy
    C L Wu
    Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA
    Urology 57:925-9. 2001
  10. ncbi The role of prostate-specific antigen velocity in prostate cancer early detection
    S R Potter
    Department of Urology, The Johns Hopkins Hospital, Baltimore, MD 21287 2101, USA
    Curr Urol Rep 1:15-9. 2000

Collaborators

Detail Information

Publications11

  1. ncbi Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer
    H B Carter
    Department of Urology, Johns Hopkins Hospital, Baltimore, MD 21287 2101, USA
    JAMA 277:1456-60. 1997
    ..To evaluate prostate-specific antigen (PSA) testing intervals that maintain the detection of curable cancer and reduce unnecessary testing...
  2. ncbi Prostate-specific antigen testing of older men
    H B Carter
    Department of Urology, The Johns Hopkins University School of Medicine, The James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, MD 21287 2101, USA
    J Natl Cancer Inst 91:1733-7. 1999
    ....
  3. ncbi Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer
    S M Harman
    The Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA
    J Clin Endocrinol Metab 85:4258-65. 2000
    ..Our data suggest that IGF-II may inhibit both prostate growth and development of prostate cancer...
  4. ncbi Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of Aging
    J Fang
    National Institute on Aging, Gerontology Research Center, Baltimore, Maryland, USA
    Urology 58:411-6. 2001
    ..Those men with the lowest risk of prostate cancer on the basis of the baseline PSA measurements are unlikely to benefit from frequent PSA surveillance in an effort to detect prostate cancer early...
  5. ncbi Prediction of significant cancer in men with stage T1c adenocarcinoma of the prostate
    H B Carter
    Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    World J Urol 15:359-63. 1997
    ..This information is useful when counseling men regarding management options for non-palpable, PSA detected prostate cancer...
  6. ncbi Dedifferentiation of prostate cancer grade with time in men followed expectantly for stage T1c disease
    J I Epstein
    Department of Urology, The Johns Hopkins University School of Medicine, The James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, Maryland 21231, USA
    J Urol 166:1688-91. 2001
    ..Furthermore, men undergoing watchful waiting can be reassured that there is little evidence that prostate cancer grade worsens during the short term...
  7. ncbi Plasma selenium level before diagnosis and the risk of prostate cancer development
    J D Brooks
    Department of Urology, Stanford University Medical Center, Stanford, California, USA
    J Urol 166:2034-8. 2001
    ..These results support the hypothesis that supplemental selenium may reduce the risk of prostate cancer. Because plasma selenium decreases with patient age, supplementation may be particularly beneficial to older men...
  8. ncbi Importance of posterolateral needle biopsies in the detection of prostate cancer
    J I Epstein
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Urology 57:1112-6. 2001
    ..Maximum cancer detection results from combining both routine sextant and posterolateral needle biopsies...
  9. ncbi Effect of local anesthetics on patient recovery after transrectal biopsy
    C L Wu
    Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA
    Urology 57:925-9. 2001
    ..CONCLUSIONS: Injection of lidocaine lateral to the seminal vesicles before prostate biopsy did not diminish biopsy-associated pain...
  10. ncbi The role of prostate-specific antigen velocity in prostate cancer early detection
    S R Potter
    Department of Urology, The Johns Hopkins Hospital, Baltimore, MD 21287 2101, USA
    Curr Urol Rep 1:15-9. 2000
    ..This review briefly summarizes the theoretic basis and clinical utility of PSAV in prostate cancer early detection...
  11. ncbi Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies
    W G Nelson
    Johns Hopkins Oncology Center, Baltimore, MD 21231, USA
    Cancer Chemother Pharmacol 46:S67-72. 2000
    ....